Grant: Team Gr.: Embracing Diversity Achieve Prec./Health Equity-HIV/AIDS/STBBI-PHP-LOI
University of British Columbia
$20,000.00
Optimizing Equitable Implementation of Doxycycline for Bacterial STI Prevention Across Key Populations
FY 2023-24
Summary
There is an ongoing epidemic of the bacterial sexually transmitted infections (STI) syphilis, chlamydia, and gonorrhea in Canada. Recent studies have shown that the use of a common antibiotic called doxycycline can help prevent these STIs in gay, bisexual and other men who have sex with men (GBM) and transgender women (TGW). However, very little work has been done on various aspects of implementation of doxycycline in GBM and TGW, such that there is concern around inequities and disparities in access, uptake, and use of this novel STI prevention tool in these key populations. Further, there has been little-to-no work done in other populations in whom STI rates are also very high, and in whom an intervention like this one may be of benefit (e.g. youth, cisgender women). This Team Grant proposes a number of different projects that will examine various factors around the implementation and use of doxycycline for STI prevention. We will focus on a number of different key populations, including cisgender women, as well as gender-diverse youth, GBM and TGW. We will also focus on key issues such as acceptability, feasibility, uptake and antibiotic resistance, looking at how various factors (e.g. age, race, stigma) impact - and are impacted by - these issues. The ultimate goal of this project is to come up with data to help inform the tailored and equitable implementation of doxycycline for STI prevention in each of the affected key populations.
Department
Program
Team Gr.: Embracing Diversity Achieve Prec./Health Equity-HIV/AIDS/STBBI-PHP-LOI
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
500708
Name
Grennan Jonathan (Troy)
Region
British Columbia
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Population and Public Health
Theme2
Clinical
Prcname2
Team Grant: Embracing Diversity to Achieve Precision & Health Equity
Projecttitle
Optimizing Equitable Implementation of Doxycycline for Bacterial STI Prevention Across Key Populations
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$20,000
Cihrequipment2
$0
Programname2
Team Gr.: Embracing Diversity Achieve Prec./Health Equity-HIV/AIDS/STBBI-PHP-LOI
Keyworddelim
Doxycycline; Gay, Bisexual, And Other Men Who Have Sex With Men; Implementation Science; Post-Exposure Prophylaxis (Pep); Pre-Exposure Prophylaxis (Prep); Sex And Gender Minorities; Sexually Transmitted Infections (Sti); Sti Prevention
Abstract
There is an ongoing epidemic of the bacterial sexually transmitted infections (STI) syphilis, chlamydia, and gonorrhea in Canada. Recent studies have shown that the use of a common antibiotic called doxycycline can help prevent these STIs in gay, bisexual and other men who have sex with men (GBM) and transgender women (TGW). However, very little work has been done on various aspects of implementation of doxycycline in GBM and TGW, such that there is concern around inequities and disparities in access, uptake, and use of this novel STI prevention tool in these key populations. Further, there has been little-to-no work done in other populations in whom STI rates are also very high, and in whom an intervention like this one may be of benefit (e.g. youth, cisgender women). This Team Grant proposes a number of different projects that will examine various factors around the implementation and use of doxycycline for STI prevention. We will focus on a number of different key populations, including cisgender women, as well as gender-diverse youth, GBM and TGW. We will also focus on key issues such as acceptability, feasibility, uptake and antibiotic resistance, looking at how various factors (e.g. age, race, stigma) impact - and are impacted by - these issues. The ultimate goal of this project is to come up with data to help inform the tailored and equitable implementation of doxycycline for STI prevention in each of the affected key populations.
Competitiondate
202402
Approvedterm2
1 yr 0 mth
Pinamesdelim
Grennan, Jonathan (Troy); Bartlett, Sofia R; Burchell, Ann N; Hull, Mark W; Tan, Darrell H
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $20,000~ $0~